Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

News und Analysen

Argenx's 28% Surge & Promising Product Propel Investor Confidence: https://www.marketbeat.com/logos/articles/med_20230924200315_argenxs-28-surge-promising-product-propel-investor.jpg
Argenx's 28% Surge & Promising Product Propel Investor Confidence

If you want to get an isolated view of a constructive base taking shape in a strong stock, take a look at the Argenix SE (NASDAQ: ARGX) chart. 

The stock gapped up nearly 28% on July 17, after

Flee to Healthcare Stocks if Recession Rears its Head?: https://www.marketbeat.com/logos/articles/med_20230919053331_flee-to-healthcare-stocks-if-recession-rears-its-h.jpg
Flee to Healthcare Stocks if Recession Rears its Head?

If you’re looking for a sector that’s on sale, look to healthcare. The Health Care Select Sector SPDR Fund (NYSEARCA: XLV) is down 2.50% in the past month, lagging the S&P 500. 

The top

Could Ely Lilly Be the Best Pharma Stock to Own Now and Forever?: https://www.marketbeat.com/logos/articles/med_20230917134923_chart-lly3.jpg
Could Ely Lilly Be the Best Pharma Stock to Own Now and Forever?

Pharmaceutical giant Eli Lilly & Co. (NYSE: LLY) stock has been on a tear, trading up 57.7% year-to-date (YTD). The company is firing on all cylinders with its leading medications and a highly

Can These 3 Healthcare Dividend Stocks Deliver Income Growth?: https://www.marketbeat.com/logos/articles/med_20230918072814_can-these-3-healthcare-dividend-stocks-deliver-inc.jpg
Can These 3 Healthcare Dividend Stocks Deliver Income Growth?

The healthcare industry presents a fertile shopping ground for undervalued dividend stocks. S&P 500 components Pfizer Inc. (NYSE: PFE), Medtronic plc (NYSE: MDT) and Gilead Sciences Inc. (NASDAQ:

High Yield, Low Beta Stocks to Buy for the Next Market Meltdown: https://www.marketbeat.com/logos/articles/med_20230911124127_chart-abbv-9112023ver002.png
High Yield, Low Beta Stocks to Buy for the Next Market Meltdown

The market's fear indicator, the VIX index, is bobbing along at long-term lows and gives little indication of a looming correction, but investors should assume one is brewing. The index is down at

Insiders Are Buying These 2 Stocks: https://www.marketbeat.com/logos/articles/med_20230908091904_insiders-are-buying-these-2-stocks.jpg
Insiders Are Buying These 2 Stocks

Understanding insider buying is crucial for savvy investors looking to make informed decisions in the stock market. Insider buying occurs when company insiders, such as executives or directors,

Rockstone Research - Homerun in Bahia: An der Spitze eines der hochwertigsten Quarzsand-Distrikte der Welt: https://www.irw-press.at/prcom/images/messages/2023/71884/Rockstone_Homerun_070923.001.jpeg
Rockstone Research - Homerun in Bahia: An der Spitze eines der hochwertigsten Quarzsand-Distrikte der Welt

Quarzsandprojekte im weltweiten Vergleich

 

Vollbild / Die große Tonnage an weißem Quarzsand in Santa Maria Eterna ist von hervorragender Qualität mit einem hohen Siliziumdioxidgehalt und

2 Stocks That Doubled EPS Estimates and Flashing Buy Signals: https://www.marketbeat.com/logos/articles/med_20230827122241_chart-edr2.jpg
2 Stocks That Doubled EPS Estimates and Flashing Buy Signals

The second quarter of the 2023 earnings season has drawn to a close. There were many surprises in every sector. However, there were some standout surprises with upcoming catalysts to watch. These

3 Takeaways from the August Inflation Report: https://www.marketbeat.com/logos/articles/med_20230831105725_chart-8312023ver001.png
3 Takeaways from the August Inflation Report

The market advanced following the August PCE price index report, but investors and traders should not discount the news. The PCE index remains cool relative to the peaks of the inflation scare,

A Significant Reversal is in Sight for These 5 Med Tech Companies: https://www.marketbeat.com/logos/articles/med_20230829084134_chart-isrg-8292023ver001.png
A Significant Reversal is in Sight for These 5 Med Tech Companies

Med tech has been on the skids for no fault of its own. It’s not the industry's fault that price action was driven to a frothy bubble by COVID-inspired trading outlooks or that the market has

5 Good Reasons it's Time to Buy High-Yield Dividend King 3M: https://www.marketbeat.com/logos/articles/med_20230829072150_chart-mmm-8292023ver001.png
5 Good Reasons it's Time to Buy High-Yield Dividend King 3M

3M (NYSE: MMM) is an interesting speculation on high-yield dividend growth and value, and now is an excellent time to take a bite. The company is navigating a difficult time with aplomb, and the

Does A 7.6% Dividend Make Walgreens A Better Buy Than CVS?: https://www.marketbeat.com/logos/articles/med_20230828140619_does-a-7.jpg
Does A 7.6% Dividend Make Walgreens A Better Buy Than CVS?

Very rarely do investors get the opportunity to consider a purchase of a high-quality asset or company at a steep discount to the overall industry it operates within. Today, there is not only one

5 High-Yielding S&P Stocks: Is It The Right Time To Buy?: https://www.marketbeat.com/logos/articles/med_20230824073050_5-high-yielding-sp-stocks-is-it-the-right-time-to.jpg
5 High-Yielding S&P Stocks: Is It The Right Time To Buy?

About three-fourths of the S&P 500 pay a dividend. According to S&P Dow Jones Indices, dividends have contributed approximately 32% of total S&P return since 1926. 

The current yield of the S&P

Eilt: Hautkrebs vollständig geheilt - Biotech Hot Stock meldet Lizenzdeal mit Nr. 1. Jetzt 223% mit Biotech Aktientip nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB): https://www.irw-press.at/prcom/images/messages/2023/71757/ac08-24-23-0ac01.001.png
Eilt: Hautkrebs vollständig geheilt - Biotech Hot Stock meldet Lizenzdeal mit Nr. 1. Jetzt 223% mit Biotech Aktientip nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB)

Eilt: Hautkrebs vollständig geheilt - Biotech Hot Stock meldet Lizenzdeal mit Nr. 1. 223% mit Biotech-Aktie nach 15.973%

 

24.08.23 08:03

AC Research

 

London (www.aktiencheck.de, Anzeige)

 

Disney's Big Breakup? Wall Street, Iger Ponder A Magical Split: https://www.marketbeat.com/logos/articles/med_20230823072921_disneys-big-breakup-wall-street-iger-ponder-a-magi.jpg
Disney's Big Breakup? Wall Street, Iger Ponder A Magical Split

For Walt Disney Co. (NYSE: DIS) shareholders, their brokerage statements haven’t exactly been the happiest place on earth. The stock has lagged the S&P 500 for the past 10 years, although it’s

2 Stocks that Historically Rise in the Fall: https://www.marketbeat.com/logos/articles/med_20230820122334_chart-unh2.jpg
2 Stocks that Historically Rise in the Fall

The start of school means that autumn is just around the corner. As temperatures drop, certain seasonal factors come into play in the country and specific industries. The stock market is a

Eilt: Sensationeller Lizenzdeal mit Nr 1 - Hautkrebs vollständig geheilt. Jetzt 214% mit dieser Biotech-Aktie nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB): https://www.irw-press.at/prcom/images/messages/2023/71744/Aktiencheck230823.001.png
Eilt: Sensationeller Lizenzdeal mit Nr 1 - Hautkrebs vollständig geheilt. Jetzt 214% mit dieser Biotech-Aktie nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB)

Eilt: Sensationeller Lizenzdeal mit Nr. 1 - Hautkrebs vollständig geheilt. Neuer Biotech Aktientip nach 31205% mit Amgen

 

23.08.23

AC Research

 

London (www.aktiencheck.de, Anzeige)

 

 

The 3 Most Promising Real Estate Stocks To Watch This Quarter: https://www.marketbeat.com/logos/articles/med_20230821185049_the-3-most-promising-real-estate-stocks-to-watch-t.jpg
The 3 Most Promising Real Estate Stocks To Watch This Quarter

Real estate is one of the backbones of the American economy. As the latter begins to pivot into a cycle of uncertainty amid FED rate hikes and inflationary concerns, the housing market will surely

Eilt: Lizenzdeal mit Nr. 1 in Israel - Hautkrebs vollständig geheilt. Neuer 212% Biotech Hot Stock  nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB): https://www.irw-press.at/prcom/images/messages/2023/71731/ac08-22-23-ac01.001.png
Eilt: Lizenzdeal mit Nr. 1 in Israel - Hautkrebs vollständig geheilt. Neuer 212% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB)

Eilt: Lizenzdeal mit Nr. 1 in Israel - Hautkrebs vollständig geheilt. Neuer Biotech Hot Stock nach 134.452% mit Biogen

 

22.08.23 08:02

AC Research

 

London (www.aktiencheck.de, Anzeige)

 

 

Are High-Yielding AT&T And Verizon Worth Buying As Prices Skid?: https://www.marketbeat.com/logos/articles/med_20230817071344_are-high-yielding-att-and-verizon-worth-buying-as.jpg
Are High-Yielding AT&T And Verizon Worth Buying As Prices Skid?

Oh, how the mighty have fallen. Back in the days when people talked of so-called “blue chip” stocks, those that seemingly could do no wrong, America’s telecom stock was AT&T Inc. (NYSE: T)

But

3 Strong Biotech Performers To Watch As Sector Nears Breakout: https://www.marketbeat.com/logos/articles/med_20230816111238_3-strong-biotech-performers-to-watch-as-sector-nea.jpg
3 Strong Biotech Performers To Watch As Sector Nears Breakout

The biotech sector, iShares Biotechnology ETF (NASDAQ: IBB), has been trading in a tight consolidation for several months. The ETF has a 50-day range of $124.38 and $131.81. While the ETF is